Rare Genetics and Hematology

Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020

OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F…

Read More »